Welcome to EU-PEARL website. The EU-PEARL Consortium makes no warranties or representations of any kind as to the content’s accuracy, currency or completeness, neither the Consortium, IMI, the European Union, EFPIA nor any party involved in creating, producing or delivering this website shall be liable for any damages, including without limitation, direct, incidental, consequential, indirect or punitive damages, arising out of access to, use of or inability to use this web site, or any errors or omissions in the content thereof. We strive to maintain all the information as timely and accurate as possible. Should you find incorrect or incomplete data on this website, please inform the webmaster, who will update the information as promptly as possible.
Copyright © EU-PEARL
Information appearing on www.eu-pearl.euis the copyright of EU-PEARL Consortium and must not be reproduced in any medium without permission. Any duplication or use of materials on this website such as text, diagrams in other electronic or printed publications is not permitted without the author’s authorization. If you wish to be granted permission to use or reproduce any of the contents of this site, please contact firstname.lastname@example.org. The images used for this website are property of the EU-PEARL Consortium or subject to free licenses for non-commercial distribution.
PERSONAL DATA PROTECTION
EU-PEARL is committed to user privacy. EU-PEARL may process your personal data, also known as personal information, in alignment with the policy on “the protection of natural persons with regard to the processing of personal data by the Union institutions, bodies, offices and agencies and on the free movement of such data, and repealing Regulation (EC) No 45/2001 and Decision No 1247/2002/EC” based on the (EU) Regulation 2018/1725 of the European Parliament and of the Council of 23 October 2018.
EU-PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and CHILDREN’S TUMOR FOUNDATION, GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION, SPRINGWORKS THERAPEUTICS INC.. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. Read more at: www.imi.europa.eu